TeresaS.SlighMD

Clinical Trials

• Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin Start of enrollment: 2008 Dec 01

  Terminated

  Phase 2

• The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01

  Completed

  Phase 2, Phase 3

• T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza Start of enrollment: 2012 Nov 01

  Completed

  Phase 1, Phase 2

• Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18

  Terminated

  Phase 2

• Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee Start of enrollment: 2013 Jun 01

  Completed

  Phase 3

• Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01

  Completed

  Phase 3

• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01

  Completed

  Phase 3

• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01

  Completed

  Phase 2

• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) Start of enrollment: 2016 May 19

  Completed

  Phase 2

• Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism Start of enrollment: 2017 Apr 03

  Completed

  Phase 1

• Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure Start of enrollment: 2017 Jun 05

  Completed

  Not Applicable

• Join now to see all